MacLean Michael F sold RNA
August 6, 2025 · Form 4 insider transaction
MacLean Michael F sold 30,914 shares of Atrium Therapeutics, Inc. at $42.73 per share, a transaction worth $1.32M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 9 days after the transaction.
Footnotes
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on July 8, 2024.; This represents a weighted-average price. These shares were sold in multiple transactions at prices ranging from $40.15 to $43.92. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.